Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Cold Spring Harbor Perspectives in Medicine|June 5, 2013
New pulmonary therapies directed at targets other than CFTRScott H Donaldson, Luis GaliettaPediatric Allergy, Immunology, and Pulmonology|August 4, 2022
CFTR Modulator Therapies for Cystic FibrosisAaron T Trimble, Scott H DonaldsonExpert Review of Respiratory Medicine|March 27, 2014
Hypertonic saline for cystic fibrosis: worth its salt?Jennifer L Goralski, Scott H DonaldsonJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 29, 2017
Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutationAaron T Trimble, Scott H DonaldsonCurrent Opinion in Pulmonary Medicine|October 10, 2003
Update on pathogenesis of cystic fibrosis lung diseaseScott H Donaldson, Richard C BoucherCurrent Opinion in Pharmacology|May 24, 2022
Current state of CFTR modulators for treatment of Cystic FibrosisKatherine A Despotes, Scott H DonaldsonAmerican Journal of Respiratory Cell and Molecular Biology|January 24, 2002
Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfacesScott H Donaldson, Maryse Picher, Richard C BoucherJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 14, 2023
Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosisKatherine A Despotes, Agathe S Ceppe, Scott H DonaldsonAnnals of the American Thoracic Society|April 27, 2016
Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic FibrosisWilliam D Bennett, Ashley G Henderson, Scott H DonaldsonPageof 7